Highlights mIL-2/CD25 is administered to cause persistent or oscillating increases in Tregs T1D in NOD mice is fully controlled only when Treg increases persist long-term mIL-2/CD25 expands Tregs, ILC2, and NK cells; the latter two also express regulatory properties Efficacy is accompanied by a reduction in the clonal expansion of autoreactive T cells
Põder et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: